BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21553660)

  • 1. Prevalence of high-risk HPV types and abnormal cervical cytology in American Indian/Alaska Native women, 2003-2005.
    Alfonsi GA; Datta SD; Mickiewicz T; Koutsky LA; Ghanem K; Hagensee M; Kerndt P; Hsu K; Weinstock H; Shlay JC
    Public Health Rep; 2011; 126(3):330-7. PubMed ID: 21553660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains.
    Bell MC; Schmidt-Grimminger D; Patrick S; Ryschon T; Linz L; Chauhan SC
    Gynecol Oncol; 2007 Nov; 107(2):236-41. PubMed ID: 17659767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999-2004.
    Becker TM; Espey DK; Lawson HW; Saraiya M; Jim MA; Waxman AG
    Cancer; 2008 Sep; 113(5 Suppl):1234-43. PubMed ID: 18720379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.
    Demers AA; Shearer B; Severini A; Lotocki R; Kliewer EV; Stopera S; Wong T; Jayaraman G
    Chronic Dis Inj Can; 2012 Sep; 32(4):177-85. PubMed ID: 23046799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.
    Datta SD; Koutsky LA; Ratelle S; Unger ER; Shlay J; McClain T; Weaver B; Kerndt P; Zenilman J; Hagensee M; Suhr CJ; Weinstock H
    Ann Intern Med; 2008 Apr; 148(7):493-500. PubMed ID: 18378945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross sectional study of HPV type prevalence according to age and cytology.
    Argyri E; Papaspyridakos S; Tsimplaki E; Michala L; Myriokefalitaki E; Papassideri I; Daskalopoulou D; Tsiaoussi I; Magiakos G; Panotopoulou E
    BMC Infect Dis; 2013 Jan; 13():53. PubMed ID: 23363541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
    J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
    PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK; Chan RC; Nichols WS; Bose S
    Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.